WO2025210486 - MICROBIOME BIOMARKERS FOR IRRITABLE BOWEL DISEASE (IBD)
National phase entry is expected:
Publication Number
WO/2025/210486
Publication Date
09.10.2025
International Application No.
PCT/IB2025/053379
International Filing Date
01.04.2025
Title **
[English]
MICROBIOME BIOMARKERS FOR IRRITABLE BOWEL DISEASE (IBD)
[French]
BIOMARQUEURS DU MICROBIOME POUR LA MALADIE DE L'INTESTIN IRRITABLE (IBD)
Applicants **
GNUBIOTICS SCIENCES SA
Inventors
ADESOKAN, Adeyemi
Priority Data
63/572,791
01.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2416 | |
| EPO | Filing, Examination, Granting | 12823 | |
| Japan | Filing, Examination, Granting | 2399 | |
| South Korea | Filing, Examination, Granting | 2573 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
26,751
Contact Us
Abstract[English]
Provided herein are methods for detecting inflammatory bowel disease (IBD) or risk of IBD in a canine based on the canine's gut microbiome. Also provided are methods for treating or preventing IBD in canines. Finally provided are probiotic compositions that are used in the methods of the present disclosure.[French]
L'invention concerne des méthodes de détection d'une maladie intestinale inflammatoire (IBD) ou d'un risque d'IBD chez un canidé sur la base du microbiome intestinal du canidé. L'invention concerne également des méthodes de traitement ou de prévention de l'IBD chez les canidés. L'invention concerne enfin des compositions probiotiques qui sont utilisées dans les procédés de la présente invention.